Adam Ketron MD PhD (He/Him)

PubMed

• 42 citations
  Phytochemicals as anticancer and chemopreventive topoisomerase II poisons
  Adam C. Ketron, Neil Osheroff
  Phytochemistry Reviews. 2014-03-01
• 51 citations
  Oxidative metabolites of curcumin poison human type II topoisomerases.
  Adam C. Ketron, Odaine N. Gordon, Claus Schneider, Neil Osheroff
  Biochemistry. 2013-01-08
• 60 citations
  Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.
  Adam C. Ketron, William A. Denny, David E. Graves, Neil Osheroff
  Biochemistry. 2012-02-28

Books/Book Chapters

• Molecular life sciences: an encyclopedic reference 
  Chapter: Topoisomerases and cancer 
  Page 1 - 19Ketron AC, Osheroff NEditors: Kaguni LS, Bell E, Wells RD, Bond JS, Klinman J, and Masters BS.Springer, New YorkEdition 1,2018
• Molecular life sciences: an encyclopedic reference 
  Chapter: Gyrase and topoisomerase IV as targets for antibacterial drugs 
  Page 489 - 493Ketron AC, Aldred KH, Lindsey RH, Osheroff NEditors: Kaguni LS, Bell E, Wells RD, Bond JS, Klinman J, and Masters BS.Springer, New YorkEdition 1,2018
• Molecular life sciences: an encyclopedic reference 
  Chapter: DNA topology and topoisomerases 
  Page 1205 - 1212Ketron AC, Osheroff NEditors: Kaguni LS, Bell E, Wells RD, Bond JS, Klinman J, and Masters BS.Springer, New YorkEdition 1,2018

Abstracts/Posters

• Neural substrates of cue reactivity among adults receiving treatment for substance use disorders: a systematic review and meta-analysis
  Ketron AC, Evohr BN, Wenzel S, Chen NT, Wade C, Janes AC, Gilman JM, 35th Annual Meeting and Scientific Symposium of the American Academy of Addiction Psychiatry, Naples, FL, 11/16/2024
• Fully remote mHealth-delivered contingency management for the treatment of methamphetamine use disorder: a qualitative analysis of patient experiences
  Ketron AC, Chang YM, Cohn EB, Duncan MH, Iles-Shih MD, Saxon AJ, Hallgren KA, 34th Annual Meeting and Scientific Symposium of the American Academy of Addiction Psychiatry, San Diego, CA, 12/9/2023
• Smartphone-based contingency management for methamphetamine use disorder: a qualitative analysis of clinician perspectives
  Chang YM, Ketron AC, Cohn EB, Saxon AJ, Iles-Shih MD, Duncan MH, Hallgren KA, 34th Annual Meeting and Scientific Symposium of the American Academy of Addiction Psychiatry, San Diego, CA, 12/9/2023
• The role of MMP-9 knockdown in induction of p53 in human breast cancer
  Ketron AC, Pourmotabbed TF, 38th Annual NIH Medical Student Research Fellowship Program Presentations at the University of Tennessee Health Science Center, Memphis, TN, 8/3/2017
• Oxidative metabolism of curcumin: products, mechanisms, and biological activity
  Gordon ON, Ketron AC, Osheroff N, Schneider C, Planta Medica 79(10):PJ3; Annual Meeting of the American Society of Pharmacognosy, St Louis, MO, 7/16/2013
• Structure-activity relationship studies of the type II topoisomerase poison amsacrine
  Ketron A, Graves D, Osheroff N, Cancer Research 71(8 Supplement):2529–2529; 102nd Annual Meeting of the American Association for Cancer Research, Orlando, FL, 4/15/2011
• Structure-function analysis of the interaction between anticancer drug amsacrine and human topoisomerase IIα and β
  Ketron AC, Graves DE, Osheroff N, 60th Southeast Regional Meeting of the American Chemical Society, Nashville, TN, 11/14/2008
• Subcellular localization of two p-type ATPases, Atp13a1 and Atp13a2
  Baldridge RD, Ketron AC, Walter JC, Ledford J, McGill DL, Martines K, Schultheis PJ, 233rd National Meeting of the American Chemical Society, Chicago, IL, 3/26/2007
• Determination of haloperidol levels in rat serum by high-performance liquid chromatography: a collaborative study
  Ketron AC, McGill DL, 231st National Meeting of the American Chemical Society, Atlanta, GA, 3/27/2006
• Join now to see all

Lectures

• Mobile health contingency management for patients with methamphetamine use: a qualitative analysis of patient and clinician experiences 
  University of Washington Department of Psychiatry and Behavioral Sciences, Seattle, WA - 6/7/2024
• Diagnosing bipolar disorder 
  Montana Family Medicine Residency Program, Billings, MT - 2/14/2024
• Medication-assisted treatment for alcohol use disorder 
  Project ECHO (Extension for Community Healthcare Outcomes) at Billings Clinic, Billings, MT - 6/21/2023
• Trauma-informed care: an overview of the attachment, regulation, and competency framework 
  Project ECHO (Extension for Community Healthcare Outcomes) at Billings Clinic, Billings, MT - 5/10/2023
• Misuse of gabapentin and related medications 
  Project ECHO (Extension for Community Healthcare Outcomes) at Billings Clinic, Billings, MT - 4/19/2023
• Cognitive behavioral therapy for insomnia 
  Project ECHO (Extension for Community Healthcare Outcomes) at Billings Clinic, Billings, MT - 12/7/2022
• Join now to see all

Other

• Improving safety and appropriateness of electronic medical record order sentence suggestions at Billings Clinic 
  Ketron AC, Birch GA, Urata K, Ollerton RD
  Billings Clinic, Billings, MT - 6/14/2024
• Synthetic and natural products as poisons of human topoisomerase II 
  Ketron AC, Dissertation
  https://ir.vanderbilt.edu/bitstream/handle/1803/11309/Ketron.pdf
  Vanderbilt University, Nashville, TN - 5/2013